Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line

Cancer Research

Volumn 59, Issue 23, 1999, Pages 6010-6014

  Krueger, Sabine ^a   Haeckel, Carsten ^a   Buehling, Frank ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; COMPLEMENTARY DNA;

ARTICLE; BONE TUMOR; CARCINOGENESIS; CELL ADHESION; CELL CLONING; CELL INVASION; CELL MOTILITY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SOUTHERN BLOTTING;

BONE NEOPLASMS; CATHEPSIN B; CELL MOVEMENT; CLONE CELLS; CLONING, MOLECULAR; DNA, ANTISENSE; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033406453     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mignatti, P., and Rifkin, D. E. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73: 161-195, 1993.
2. Liotta, L. A., and Stetler-Stevenson, W. G. Metalloproteinases and cancer invasion. Semin. Cancer Biol., 2: 99-106, 1990.
3. Schmidt, M., Jaenicke, F., Moniwa, N., Chucholowski, N., Pache, L., and Graeff, H. Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe-Seyler, 373: 611-622, 1992.
4. Kane, S. E., and Gottesman, M. M. The role of cathepsin L in malignant transformation. Semin. Cancer Biol., 2: 127-136, 1990.
5. Sloane, B. F., Moin, K., Krepela, E., and Rozhin, J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metastasis Rev., 9: 333-352, 1990.
6. Berquin, I. M., and Sloane, B. F. Cysteine proteases and tumor progression. Perspect. Drug Discovery Des., 2: 371-388, 1994.
7. Keppler, D., Waridel, P., Abrahamson, M., Bachmann, D., Berdoz, J., and Sordat, B. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim. Biophys. Acta, 1226: 117-125, 1994.
8. Sloane, B. F., Moin, K., Sameni, M., Tait, L. R., Rozhin, J., and Ziegler, G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J. Cell Sci. (Washington DC), 107: 373-384, 1994.
9. Frosch, B. A., Berquin, I., Emmert-Buck, M. R., Moin, K., and Sloane, B. F. Molecular regulation, membrane association and secretion of tumor cathepsin B. APMIS, 107: 28-37, 1999.
10. Kobayashi, H., Moniwa, N., Sugimura, M., Shinohara, H., Ohi, H., and Terao, T. Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. Biochim. Biophys. Acta, 1178: 55-62, 1993.
11. Rozhin, J., Sameni, M., Ziegler, G., and Sloane, B. J. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res., 54: 6517-6525, 1994.
12. Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Günzler, W. A., Jänicke, F., and Graeff, H. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA). J. Biol. Chem., 266: 5147-5152, 1991.
13. Kobayashi, H., Ohi, H., Sugimura, M., Shinohara, H., Fujii, T., and Terao, T. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase plasminogen activator and cathepsin B. Cancer Res., 52: 3610-3614, 1992.
14. Kolkhorst, V., Stürzebecher, J., and Wiederanders, B. Inhibition of tumor cell invasion by protease inhibitors: correlation with the protease profile. J. Cancer Res. Clin. Oncol., 124: 598-606, 1998.
15. Fong, D., Calhoun, D. H., Hsieh, W. D., Lee, B., and Wells, R. D. Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. Proc. Natl. Acad. Sci. USA, 83: 2909-2913, 1986.
16. Campo, E., Munoz, J., Miquel, R., Palacin, A., Cardesa, A., Sloane, B. F., and Emmert-Buck, M. R. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am. J. Pathol., 145: 301-309, 1994.
17. Mumane, M. J., Sheahan, K., Ozdemirli, M., and Shuja, S. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res., 51: 1137-1142, 1991.
18. Sinha, A. A., Gleason, D, F., Staley, N. A., Wilson, M. J., Sameni, M., and Sloane, B. F. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Anat. Rec., 241: 353-362, 1995.
19. Redwood, S. M., Liu, B. C., Weiss, R. E., Hodge, D. E., and Droller, M. J. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer (Phila.), 69: 1212-1219, 1992.
20. Van Noorden, C. J. F., Jonges, T. G. N., Marle, J. V., Bissel, E. R., Griffini, P., Jans, M., Snel, J., and Smith, E. Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin. Exp. Metastasis, 16: 159-167, 1998.
21. Elliott, E., and Sloane, B. F. The cysteine protease cathepsin B in cancer. Perspect. Drug Discovery Des., 6: 12-32, 1996.
22. Hélène, C., and Toulmé, J-J. Specific regulation of gene expression by antisense, sense and antigen nucleic acids. Biochim. Biophys. Acta, 1049: 99-125, 1990.
23. Wormington, W. M. Stable repression of ribosomal protein L1 synthesis in Xenopus oocytes by microinjection of antisense RNA. Proc. Natl. Acad. Sci. USA, 83: 8639-8643, 1986.
24. Kasid, U., Pfeiffer, A., Brennan, T., Beckett, M., Weichselbaum, R. R., Dritschilo, A., and Mark, G. E. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science (Washington DC), 243: 1354-1356, 1989.
25. Kariko, K., Kuo, A., Boyd, D., Okada, S. S., Cines, D. B., and Barnathan, E. S. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res., 53: 3109-3117, 1993.
26. Mohanam, S., Chintala, S. K., Go, Y., Bhattacharya, A., Venkaiah, B., Boyd, D., Gokaslan, Z. L., Sawaya, R., and Rao, J. S. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene, 14: 1351-1359, 1997.
27. Watanabe, M., Takahashi, Y., Ohta, T., Mai, M., Sasaki, T., and Seiki, M. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer (Phila.), 77(Suppl. 8): 1676-1680, 1996.
28. Mikkelsen, T., Yan, P. S., Ho, K. L., Sameni, M., Sloane, B. F., and Rosenblum, M. L. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J. Neurosurg., 83: 285-290, 1995.
29. Haeckel, C., Krueger, S., and Roessner, A. Antisense inhibition of urokinase: effect on malignancy in a human osteosarcoma cell line. Int. J. Cancer., 77: 153-160, 1998.
30. Sexton, P. S., and Cox, J. L. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C. Melanoma Res., 7: 97-101, 1997.
31. Lu, H., Mabilat, C., Yeh, P., Guitton, J. D., Li, H., Pouchelet, M., Shoevaert, D., Lebrand, Y., Soria, J., and Soria, C. Blockage of urokinase receptor reduces in vitro motility and the deformability of endothelial cells. FEBS Lett., 380: 21-24, 1996.
32. Waltz, D. A., and Chapman, H. A. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem., 269: 14746-14750, 1994.